Carlyle Group Inc. Hille Vax, Inc. Transaction History
Carlyle Group Inc.
- $80.7 Million
- Q2 2025
A detailed history of Carlyle Group Inc. transactions in Hille Vax, Inc. stock. As of the latest transaction made, Carlyle Group Inc. holds 1,838,486 shares of HLVX stock, worth $3.84 Million. This represents 4.53% of its overall portfolio holdings.
Number of Shares
1,838,486
Previous 1,838,486
-0.0%
Holding current value
$3.84 Million
Previous $2.67 Million
37.26%
% of portfolio
4.53%
Previous 3.3%
Shares
1 transactions
Others Institutions Holding HLVX
# of Institutions
74Shares Held
36.1MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$22.2 Million1.11% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$10.3 Million0.59% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.42MShares$5.06 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.37 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.95MShares$4.08 Million0.0% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.9M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.